IDH2 and central nervous system cancer: Of note, IDH-mutant gliomas of the WHO CNS grade 2 are mostly non-enhancing on MRI and usually evaluated solely based on a hyperintense signal extension of FLAIR- or T2-weighted MRI sequences.